Gemina Laboratories Ltd.
GLABF · OTC
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | -$0 | -$0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | 100% | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -6,358.2% | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -6,994.2% | – |
| EPS Diluted | -0.003 | -0.004 | -0.01 | -0.019 |
| % Growth | 20.5% | 62.5% | 46.4% | – |
| Operating Cash Flow | $0 | -$0 | $0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | -$0 | $0 | -$0 |